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The virus of equine encephalomyelitis appears  in the blood in the 
natural infection of horses before the appearance of clinical symptoms, 
and epidemiological and experimental findings favor the view that it 
is disseminated by insect vectors (1),  especially the mosquito (2-4). 
Were immunization attempted by the use of active virus, the danger 
might arise of bringing about either lethal encephalitis, or blood infec- 
tion in animals showing no clinical symptoms, thus producing in both 
instances suitable  conditions for insect transmission of the disease. 
Hence an effective method of immunization without employing active 
virus would be clearly advantageous. 
We regarded the possibility of immunizing animals with this virus, 
almost or completely  inactivated by chemical means, with considerable 
skepticism in view of the number of failures  thus far  reported with 
other viruses.  They had yielded results that were not hopeful, or at 
best inconclusive. 
Early attempts were made with virus treated with phenol, glycerol 
containing phenol, chloroform, saponin, merthiolate, tannic acid, and 
aluminum hydroxide (5, 6).  These procedures proved unsatisfactory 
because  either  inactivation could not be  obtained or  the  antigenic 
powers of the treated virus were reduced below the desired degree. 
In our hands, however, the use of formalin gave more promise.  After 
these studies were begun, an article appeared by Shahan and  Gilt- 
ner (7) in which was described the successful immunization of horses, 
both in the laboratory and in the field, with virus inactivated by 0.4 
per cent formalin.  Of over 400 horses, each given two doses of 25 cc. 
of the vaccine, none developed disease.  After 6 to 16 weeks, of thir- 
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teen  vaccinated  animals  receiving  an  intralingual  test  dose  that  in- 
duced disease in all of thirteen controls, nine withstood the inoculation. 
Howitt, on the other hand (6), recorded inconclusive results in guinea 
pigs  treated  with  1  per  cent  formolized  virus.  We  continued  our 
investigations on formolized virus, and in view of the generally saris- 
factory outcome of Shahan  and  Giltner's earlier experiments  (7), we 
adapted  their method, with certain modifications,  to our study. 
In this paper we present experimental evidence to show first that it 
is possible to induce in guinea pigs and mice a high degree of resistance 
against infection by the use of formolized material in which the virus 
is inactivated, or reduced to an amount well below its ordinary minimal 
dose for effective immunization  (5)3  Secondly, we offer experiments 
on  the  mechanism of the  induced  immunity,  especially with  respect 
to  the  possible  activity  of any  residual  or  undetected  virus  present 
in such preparations. 
Materials and Methods 
Virus.--The Eastern strain of equine encephalomyelitis (8), more highly inva- 
sire for guinea pigs and mice than the Western, was employed as  fresh or gly- 
cerolated guinea pig or mouse  brain. 
Titration of Virus Infectivity.--In the first experiments the maximal infectivity 
of the virus sample before formolization was not determined.  It was noted later 
that vaccines made in the same way but with  virus from different sources mani- 
fested unequal immunizing powers.  It was inferred that these differences might 
have been related to quantity  of virus in the source material.  In later prepara- 
tions it was therefore titrated before adding formalin.  To titrate, the method of 
intracerebral injection of anesthetized mice was employed as already described (5). 
A noteworthy point is that hormone broth pH 7.4 was used as diluent in titrations 
since repeated observations have shown that saline solution as a diluent reduces 
the  end-point of activity of fresh or dried  virus  10  to  100-fold.  In addition, 
l In the first paper of this series (5) it was found that 3,000 to 30,000 mouse 
infective units of untreated,  active virus  (m.i.u.)  injected subcutaneously three 
times at weekly intervals are required to protect guinea pigs against 1,000 or more 
intracerebral lethal doses and one or two such injections are required to induce 
resistance against experimental infection by way of the nose or subcutis.  Larger 
quantities, even when given less than three times, are also immunizing but then 
the incidence of fever, blood infection,  and death during the period of immuniza- 
tion increases; and in proportion as the optimal dosage, as mentioned, is decreased, 
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infected  mouse  brain per unit weight  was found,  as a  rule,  to possess  greater 
infectivity  after  intracerebral  inoculation  of  mice  than  guinea  pig  brain:  the 
limiting infective dilution  of the former being ordinarily 0.03 cc. of I0  -v to 10  -s 
and of guinea pig tissue 0.03 cc. of 10  -s (occasionally  I0  -v) dilutions. 
Preparation of Vaccine.--Infected mouse or guinea pig brain was ground with 
sterile sand and 0.85 per cent saline solution  to a 20 per cent suspension.  This 
was filtered through at least eight layers of sterile cotton gauze.  A portion of the 
filtrate  was  removed  for  titration  and  to  the  remainder  was  added  an  equal 
volume of 0.8 to 2 per cent formalin  in saline solution.  The mixture  was kept 
at room temperature for i  to 4 days and then stored  at 5°C. for 3 to 65 days 
until  used.  Before  injecting  the  vaccine  into  animals,  the  formalin  was  neu- 
tralized  by  ammonium hydroxide  against  phenolphthalein  indicator  to  avoid 
toxic reactions. 
Procedure of Immunization.--Guinea pigs were injected  subcutaneously  twice 
at 5 to 9 days' interval with i  cc. each time of the same vaccine.  Exceptional 
dosages will be mentioned  in the text.  In order to obtain additional  evidence of 
the  immunizing  capacity of the materials  in another host,  mice  were  injected 
intracerebrally  (0.03 cc.) and  also  intraperitoneally  or  subcutaneously  (0.2 to 
0.5 cc.), foUowed after 7 days by a similar intraperitoneal  or subcutaneous  dose. 
Tests for Induced Immunity.--To  obviate cross  tissue  reactions  in  tests  for 
immunity, guinea pigs received only guinea pig passage  virus  and mice, mouse 
passage material.  A suitable  number of untreated control animals was included 
in each  test and these were injected  last to minimize virus  deterioration.  The 
immunity  tests  were  given  intracerebrally,  intranasally,  and  subcutaneously. 
The intracerebral  inoculation--more drastic,  and containing,  as a  rule,  I00 to 
1,000 lethal doses--consisted of 0.15 cc. for guinea  pigs and 0.03 cc. for mice. 
Desiccated  virus was found to be preferable for this use since its potency could 
be better controlled.  The intranasal  test in guinea pigs consisted of an instilla- 
tion of 0.05 cc. of freshly prepared  i0 per cent virus in broth in each nostril,  and 
the subcutaneous  test of i  cc. of this material.  The nasal and cutaneous  tests 
have been discussed in the first paper (5) and ordinarily  represent  at least I  to 
I0 M.T..D. 
Attempts  to  Find  Active  Virus  in  Formolized  Preparations.--The 
determination, as completely as was possible, of the degree of inactiva- 
tion of virus in the formalin preparations used for immunization was 
for the present problem of utmost importance,  For one phase of the 
problem concerned the question of whether protection against experi- 
mental infection with formolized material was due to residual active 
virus or to "killed" virus.  All available methods were therefore em- 
ployed intensively in the search for active virus in the fifteen formol 
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can be classified as follows:  (1)  Intracerebral inoculation of vaccines 
in mice and guinea pigs together with simultaneous intraperitoneal or 
subcutaneous  injection  of  massive  doses  (up  to  8  cc.).  (2)  Serial 
(three  to  four)  passages  in  mouse  and  guinea pig  brain  of cerebral 
tissue  ~ inoculated with vaccines.  (3)  Search for active virus in blood, 
skin  at  site  of injection,  regional lymph nodes,  spleen,  liver,  lungs, 
testis or ovary, kidney,  brain,  and  cord of animals  treated as in  1. 
(4)  Inoculation of tissue  cultures with as much as  1 cc.  of vaccines 
to each culture flask.  This is a new method devised for the purpose of 
testing the same amount of the vaccine as is used in the animal and 
is  more  sensitive  in  detecting  virus  than  is  animal  inoculation  (9). 
(5)  Concentration of vaccine fivefold by vacuum distillation and desic- 
cation followed by Methods 1, 2, 3, and 4.  (6)  Dilution method (10) : 
(a)  direct dilution;  (b)  dilution  and keeping at  37°C.  for as long as 
10 days followed by tests each day by Methods 1, 2, and 4. 
The following examples are given of the numerous attempts made to recover 
active virus from the vaccines. 
Method 1.--327 mice and forty guinea pigs received intracerebral and subcu- 
taneous or intraperitoneal injections of undiluted ammonium hydroxide-neutral- 
ized vaccines--fourteen being employed in mice and seven in guinea pigs.  Mice 
received 0.03 co. in the brain and 0.2 to 0.5 cc. by the other routes, while guinea 
pigs were given 0.15 cc. intracerebrally and 1 to 8 cc. subcutaneously or intra- 
peritoneaUy. 
Method 2.--54 mice and six guinea pigs were employed in an effort to recover 
active virus from three of the formol preparations by serial passage in brain tissue, 
as outlined above. 
Method  3.--Twenty-eight anesthetized guinea pigs receiving  eleven different 
vaccines were bled from the heart on the 2nd to the 14th day after intracerebral 
and subcutaneous injection of vaccine, and each specimen so obtained was tested 
for virus by intracerebral injection of four mice.  Twelve guinea pigs  treated 
similarly with three formolized preparations were killed on the 2nd to 7th day 
after the vaccine injection and a total of 384 mice were used in the attempt to 
detect virus in the different organs mentioned, and in the blood.  Each of the 
tissues  was ground to an approximate 10 per cent suspension  in hormone broth 
pH 7.6 and after centrifugation at 2,000 g.1,.x¢, for 10 minutes, the supernatant 
fluid was injected into the brains of four mice. 
Method 4.--59 tissue cultures were each inoculated with from 0.5 to 1 cc. of 
undiluted, formol-neutralized material derived from three different vaccines. 
2 All such operations were made with the aid of full ether anesthesia. III~RALD  R. COX  AND  PETER  K. OLITSKY  749 
Method 5.--Nine guinea pigs received 0.15 cc. intracerebrally  and 1.5 cc. subcu- 
taneously of a  formol preparation concentrated fivefold by vacuum distillation 
and desiccation.  One of the animals was killed on the 2nd, another on the 4th, 
and a third on the 6th day after treatment.  In each case the organs as described 
in Method 3 were tested for the presence of virus by mouse injection. 
Method 6.--Eight of the formol vaccines were diluted  and over 160 mice were 
used  in these  tests. 
These  tests  were  considered  to  be  fully sufficient  to  indicate  the 
presence  of  virus  in  the  formolized  preparations,  inasmuch  as  the 
quantities put to test were even larger than .the immunizing dose given 
to  animals.  The vaccines,  thoroughly studied  by means of the  de- 
scribed methods, showed that thirteen of fifteen failed to yield virus 
(Tables I and II).  A description of the two materials which contained 
a  barely detectable quantity of virus follows. 
Vaccine  V,  undiluted  and  diluted  10  -1,  10  -~,  10  ~,  and  10  -4,  was  injected 
5 days after its preparation in the brain and peritoneal cavity of a total of 60 mice. 
Only two of twenty mice receiving the undiluted,  and one of ten the  10  -~ dilu- 
tion developed  the lethal virus disease,  although after a  prolonged  incubation 
period  (7 to 8 days).  The same vaccine, undiluted,  tested 2 days later, showed 
no virus.  With it eight guinea pigs were injected  intracerebrally  (these animals 
are equally  as reactive  as mice after such  injection)  and also intraperitoneally 
and subcutaneously  with 1.5 to 8  cc.  They were unaffected.  Of three guinea 
pigs of the group just  cited  which received the 8 cc. dosage, one was sacrificed 
on the 3rd,  a second on the 4th,  and a  third on the 7th day after inoculation, 
and by means of the mouse intracerebral  test,  no virus was recovered from their 
blood  or tissues.  In addition,  three of the  remaining  five guinea  pigs  of  this 
group were submitted to an  intracerebral  test of 1,000 M.L.~. 1 month after the 
primary inoculation  and all survived.  We believe  that while meagre  amounts 
of active virus were present  in this vaccine  (V) on the 5th and none on the 7th 
day after its preparation,  yet the substance  was highly antigenic.  This induced 
resistance,  brought about with what is  apparently virus-free  material,  will be 
described later. 
Vaccine XIII (Table II).  Only one of eighteen mice receiving the undiluted 
vaccine in the brain and subcutis on the 5th day after its preparation succumbed 
to virus  encephalitis;  twenty mice given 10  -1 and 10  -3 dilutions  remained  well. 
It is of interest  that of four guinea pigs first treated with this vaccine on the day 
the latter showed the minute amount of virus,  all failed to resist from 1,000 to 
3,000 Xf.L.D. injected  cerebrally  77 days later.  The latter observation confirms 
other data to be presented  pointing  to the immunizing action of formolized ma- 
terial as being due to some other factor than to residual active virus. 7~0  IMMUNIZATION  WITH  ENCEPHALOMYELITIS  VIRUS.  II 
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Thus two of fifteen formolized vaccines contained barely detectable 
amounts of virus; one was immunizing; the other not.  The one which 
was antigenic was, interestingly enough, the vaccine that contained no 
detectable virus at the time of its use in preventive inoculation. 
Immunizing Capacity of Formolized Preparations of Virus 
It is clear from the foregoing section that the formalin treatment 
either wholly inactivates the virus or, in exceptional instances, reduces 
its quantity to a point at which it by itself is not the factor involved 
in inducing immunity, as was shown in the preceding paper (5).  The 
question now is whether such material is effective as a vaccine for the 
production of resistance against infection with the usual test doses. 
The answer is to be found in the data listed in Table I. 
Reference to the table reveals that protection was acquired by 103 
of  107  guinea pigs receiving subcutaneous injections of the thirteen 
different samples of formolized vaccines in which virus could not be 
detected by the recorded methods.  Moreover, the vaccines were kept 
in the cold up to 65 days and still possessed the capacity to immunize; 
and the period of acquired resistance endured for at least 92  days-- 
the duration of protection over longer intervals will be described later. 
The  test dose  for induced immunity was  given either intranasally, 
subcutaneously, or intracerebrally and in the latter instance consisted, 
as a  rule, of 1,000 M.L.D. or more. 
Two of the fifteen formolized preparations were  wholly ineffective 
for immunization (vaccines VII and XIII, Table  II)  and two were 
only partially  antigenic  (vaccines  IV  and  VIII,  Tables  I  and II). 
Vaccines VII and XIII were prepared from glycerolated material, and one 
of them (XIII) was already referred to as containing a minimum of active virus 
at the time of its use.  The latter material showed  a relatively low titre of 3 X 104 
m.i.u, before formolization and the effect of glycerolation on reduction of anti- 
genicity is illustrated by the following  experiment. 
Vaccine X  (effective) was prepared from the fresh, left cerebral hemispheres 
derived from ten guinea pigs prostrate  from the  experimental disease, while 
vaccine XIII  (ineffective) was made from the right  hemispheres of the same 
animals but after storage in 50 per cent glycerol for 25 days at 5°C.  Storage  in 
glycerol diminished the virus activity in the tissue by about 100 fold. 
No  titrations  were made with the materials  entering into the composition 
of vaccine VII. le 
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In vaccine IV the usual technique was modified  without good results (Table II), 
while vaccine VIII was only partially effective; its virus content was not deter- 
mined prior to formolization. 
It would appear,  therefore, that the method of preparation of the 
vaccines is significant.  We may state that within our experience up 
to  the  present  time  fresh  (not  glycerolated),  infected brain  tissue 
derived from mice  3 and guinea pigs, and tissue having a high content of 
active virus before formolization, should be used preferably. 
Duration of Induced Immunity.--As shown in Table III,  twelve of 
thirteen  guinea pigs  survived  an  intracerebral  test  of  1,000  M.L.D. 
at least, given from 80 to 92 days after the last injection, or from 87 
to  99  days  after  the  first  treatment.  The  only  animal  that  suc- 
cumbed to the test was one of three receiving one  immunizing dose. 
The indication is that two injections of the vaccine are more effective 
than one, as will be shown again later (see also Tables III, IV, and V). 
Table III presents results which refer to the duration of resistance 
over relatively shorter periods of time than those given in Table IV. 
It will be noted from the latter table that in the intervals  extending 
from 126 to 200 days after vaccination with the formolized prepara- 
tions, immunity still persisted, although somewhat reduced in  degree 
following an intracerebral test but yet fairly solid after the subcutane- 
ous or intranasal tests for induced resistance.  When compared with 
the protection conferred by active virus over prolonged periods of time, 
from 185 to 240 days after vaccination (Table IV), the results point to 
the fact that while animals immunized with untreated virus withstand 
the intracerebral test for resistance to a higher degree, there is no sig- 
nificant difference between untreated and formolized virus vaccines 
in  their  respective capacities  to  induce protection  against  nasal  or 
subcutaneous experimental infection--infection more closely simulat- 
ing what occurs in nature--during the period of time studied. 
Stability  of Antigenic  Power.--The  antigenic stability  of  the  for- 
molized preparations is well illustrated in the records of vaccines III 
and XI  (Table I).  They retained their immunizing property after 
storage at 5°C. for 63 and 65 days respectively. 
3  As shown in Table I, effective vaccines were prepared from mouse brain 
stored in the cold in Petri plates for as long as 17 to 19 days. HERALD  R.  COX  AND  PETER  K.  OLITSKY  755 
In both materials  the formalin was not neutralized  by ammonium hydroxide 
until just before animal inoculation.  By way of contrast, vaccine IV, neutralized 
just after inactivation by formalin had been completed, rapidly lost its capacity 
to immunize (Table II). 
Relation  of Dose and Dilution of Vaccines  to Induced Immunity.~ 
The results thus far tabulated consistently show a relation of the dose 
TABLE  III 
Duration of Immunity in Guinea Pigs against Intracerebral Infection 
II 
XI 
XII 
XII 
XII 
t 
T. 
p 
FGB 
FMB  5°C. 
8d. 
F M B  5°C. 
17d. 
o 
o 
Not tested  Negative 
3  X  107  " 
3  X  108 
3 X  108 
3X108 
days 
4 
12 
Immunization 
sc, 1 CO. 
each, 6 d.J 
int. 
sc~ 1 CO. 
each, 7 d. 
int. 
SC~ 1 CC. 
SC, 2 CC. 
SC~  i  CC. 
each, 7 d. 
int. 
~.~ 
~-~ 
days 
75 
92 
87 
87 
80 
Test for immunity 
z 
>IO<IOC  1/1" 
>I,000  4/4 
>t,ooo  2/3 
>1,000  3/3 
>1,000  3/3 
Abbreviations as in Table I. 
* Only one animal of a series survived intercurrent infections during the period 
prior to the immunity test. 
of a  vaccine to the immunity induced in guinea pigs.  Consequently 
two  injections,  each of  1  cc.,  are  practical  for immunization.  The 
relation  of  quantity  is  again  brought  out  in  experiments  on  mice, 
summarized in  Table  V.  Undiluted preparations  yielded complete, 
whereas  10  -1  dilution, little or no protection,  and still greater  dilu- 
tions none. 756  IMMUNIZATION  WITH  ENCEPHALOMYELITIS  VIRUS.  II 
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Comparison of Formolized and Untreated, Active  Virus 
A  comparison was now attempted with formolized virus on the one 
hand and with active virus on the other, on the respective degrees of 
immunity  developed  in  mice  and  guinea  pigs.  As  a  corollary,  the 
test of adding small, known amounts of virus to ineffective, formolized 
tissue was performed to  determine whether such virus was antigenic 
since, as has been shown (5), these small quantities were not immuniz- 
ing by themselves. 
1.  Tests with the Mouse.--The optimal dosage of active virus needed to protect 
guinea pigs uniformly against  1,000 ~.L.D. given by way of the brain has already 
been  defined in  a  foregoing section.  Similarly  to  build  up resistance  in  mice 
regularly  against  twenty to fifty intracerebral  lethal  doses,  600 to 6,000 m.i.u. 
of virus  given intraperitoneally  twice at 7 days' interval  are  required.  But, as 
shown  in  Table  V,  such  amounts  of  active  virus,  although  the  optimum  for 
immunization,  are dangerous  to the mouse,  since of ten animals  receiving  this 
treatment,  two succumbed  to virus  infection.  Even subliminal  quantities  pro- 
duced fatal infection.  On  the other hand,  solid  resistance  was  obtained  witfi 
safety by the use of the adequate dose of formolized vaccine, in which it was not 
possible  to detect active  virus  (Table  V). 
2.  Tests with the Guinea Pig.--Tables VI and VII summarize  the results  of a 
large  number of experiments  on comparison  of active virus,  as such,  and for- 
molized vaccines  as  immunizing  materials.  It  is  clear  that  guinea  pigs  were 
rendered  resistant  to as  many as  1,000 intracerebral  lethal  doses  by means  of 
formolized vaccines  in which  it was impossible  to demonstrate the presence of 
active virus.  It is equally plain that to obtain the same degree of resistance  by 
means  of  active virus  itself,  it  was  found necessary  to  inject  subcutaneously 
3,000 to 30,000 m.i.u,  three times  at  7 days' interval. 
Forty guinea pigs resisted  an intracerebral  test of over 1,000 M.L.I). 17 to 99 
days after immunization with formolized virus was begun.  Thirty-seven of them 
withstood  a repeated,  similar intracerebral  test  14 to 90 days following the first 
test,  and all of six were protected against a third intracerebral  dose of over 1,000 
M.L.D. given 78 days after the second test (or 128 days after vaccination was begun). 
3. Effect of Minute Amounts of Virus Added to Formolized Tissue.--The object 
of this  experiment  was  to determine  whether  minute  amounts of virus in  the 
presence of large amounts of formolized tissue may be antigenic,  when either by 
itself  was  non-immunizing. 
Vaccine XIII was stored  at 5°C. for 6 months.  At the end of this time,  no 
active virus could be demonstrated in it by inoculation  of either  tissue  cultures 
or mice.  To formalin-neutralized  portions of the material  were added  known 
quantities  of active  virus  and  guinea  pigs  were injected  subcutaneously  with 
the mixtures.  The presence of active virus  in the mixtures  was manifested  by HERALD  R.  COX  AND  PETER  K.  OLITSKY  759 
inoculation of  tissue  cultures  and  mice.  The  experiment  is  summarized  in 
Table VIII and reveals that ineffective formolized material was still inert when 
TABLE  VI 
Comparative Antigenic Effects of Active and Formolized Virus 
(Specimen Pattern of an Immunity Test) 
Immunization 
Route and dose 
Virus (dried) 
No. of m.i.u, in  Formolized  dilution 
active virus  vaccine 
1 sc, 3  X  los 
1 sc, 3  X  l0  T 
1 sc, 3  X  los 
1 so, 3 X  los 
2 sc, 3 X  los each, 
7 &int. 
1 sc, 3  X  los 
2 sc, 3 ×  los each, 
7 d. int. 
3 so, 3 X  10' each, 
7 d. int. 
1 sc, 3  X  l0  s 
2 sc, 3 X  los each, 
7 d. int. 
3 sc, 3 X  los each, 
7 d. int. 
1 sc, 3 X  102 
2 sc, 3 X  los each, 
7 d. int. 
3 sc, 3 X los each, 
7 d. int. 
XlV.  2  sc,  1  cc. 
each, 7 d. int. 
Controls 
lc 
Interval 
between  I 
last injec-  I 
tion and 
"  immunity 
•  t(  st 
I  days  I 
38 
38 
38 
38 
31 
31 
31 
31 
31 
31 
31 
31 
31 
31 
38 
Intracerebral test  for immunity 
1:25 
1:25 
1:25 
1:25 
1:25 
1:25 
1:25 
1:25 
1:25 
1:25 
1:25- 
1:25 
1:25 
1:25 
1:25 
1:25 
1:250 
1:2,500 
1:10,000 
1:25,000 
1:100,000 
M.L.D. 
1,000 
1,000 
1,000 
1,000 
1,000 
1,000 
1,000 
1,000 
1,000 
1,000 
1,000 
1,000 
1,000 
1,000 
1,000 
1,000 
10G 
10 
>2<. 
1 
Result 
No. of survivors 
2/3 
5/5 
5/6 
5/5 
6/6 
2/5 
8/8 
6/6 
3/5 
5/5 
sis 
0/4 
0/4 
0/4 
s/s 
0/9 
0/2 
0/2 
0/2 
0/2 
2/2 
Abbreviations as in Table I. 
known quantities of active mouse passage virus were added.  Resistance to test 
doses was induced only when the amounts of active virus added approached the 
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TABLE  VII 
Comparative Antigenic Effect of Active and Formolized Virus 
Material used for immunization 
No. of weekly 
injections 
No. of mouse infective units in 
active virus 
3  X10  s to3  X  IO  s 
Formollzed 
vaccine 
Interval between 
last injection 
and immunity 
test 
days 
15 to 38 
3  X  10  5 
3XlO ~ 
3X  I0  sto3  X  10  4 
3X  10  3to3X  10  ~ 
3  X  10  a to3  X  10' 
3XIO ~ 
3XlO  ~ 
3XlO= 
M 
1 cc. at 7 day 
interval 
15 to 38 
15 to 110 
15 to 38 
15 to 38 
15 to 110 
15 to 38 
15 to 38 
15 to 38 
12 to 92 
Immunity to 
1,000 or more 
intracerebral 
lethal doses 
Result 
No. of survivors 
21/23 
12/14 
13/14 
8/33 
15/31 
¢~/65 
0/27 
o/13 
2/12 
TABLE  VIII 
Formolized  Vaccine* to  Which  Known  Quantities  of Active  Virus  Were  Added 
No. of weekly 
injections 
Material used for immunization 
(1 cc. of vaccine or broth) 
Vaccine +  broth 
Vaccine +  30 to 150 m.i.u, in broth 
Vaccine +  300 to 1,500 m.i.u, in broth 
Vaccine +  3,000 to 15,000 m.i.u, in broth 
Broth +  30 to 150 miu. in broth 
Broth +  300 to 1,500 m.i.u, in broth 
Broth +  3,000 to 15,000 m.i.u, in broth 
Immunity after 
14 days to 1,000 
or more intracere- 
bral lethal doses 
Result 
'No. of survivors 
1/s 
1/8 
4/8 
Vs 
0/8 
2/8 
3/8 
* This vaccine had been shown to be deficient in antigenic capacity (Table II, 
vaccine XIII). 
The somewhat better results exhibited by 300 to 1,500 units of virus added to 
vaccine over the same mount  of virus in broth may be ascribed  to summation 
effect  of  two  substances  which,  when  used  separately,  had  only  little  effect 
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Thus, large amounts of tissue do not activate small amounts of virus to become 
antigenic. 
The three groups of experiments included in  this section yielded 
results which are in agreement with each other and focus to the point 
that the virus, inactivated by formalin, still retains  the capacity of 
inducing immunity.  The degree of resistance produced by formolized 
virus is similar to that developed by untreated active virus and the 
protection conferred is not due to residual virus which may possibly 
be present in the vaccines.  4 
Recapitulation 
Before discussing the experimental results, a summary of this study 
is indicated. 
Guinea pigs can be rendered resistant to as many as  1,000 intra- 
cerebral lethal doses by the use of suitable preparations of virus which 
have been, in a practical sense, wholly inactivated by the addition of 
formalin.  Suitable preparations are those made with tissue which is 
non-glycerolated and has a high content of virus before formolization, 
and in which the chemical is not neutralized until just before use in 
animals.  These conditions have been disclosed thus far by the present 
experiments but the future may yet reveal other refinements in tech- 
nique.  The vaccines so prepared hold their antigenicity after storing 
for over 2 months.  Not only guinea pigs but mice as well can be 
rendered immune by means of formolized virus. 
The induced resistance is increased or diminished depending on the 
amount of the material given.  The optimal dose for guinea pigs is 
two subcutaneous injections of 1 cc. each spaced about a week apart 
and for mice, 0.5 cc. subcutaneously or intraperitoneally at the same 
interval. 
To obtain the same degree of protection by use of untreated active 
virus, it is necessary to inject guinea pigs subcutaneously with 3,000 
to 30,000  mouse intracerebral units of virus three times at  7  days' 
* A study on passive immunity (i.e.,  antiviral  bodies produced  in guinea pigs 
by preparations containing  active  and inactivated virus)  will be the subject  of 
another communication.  Although such bodies were found in both instances, the 
technical  difificulties of their  demonstration require  an account too lengthy for 
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interval, and mice with 500 to 6,000 units, twice at the same periods 
of time.  On comparison of the duration of induced resistance brought 
about by formolized, inactivated virus and by untreated active virus, 
one finds that the protection is as solid in the one as in the other within 
a period of about 3 months after vaccination.  During longer periods, 
that is, from 3 to about 7 months (the longest time thus far studied), 
the resistance of the animals treated with formolized vaccine is some- 
what lessened against an intracerebral test as compared with that de- 
veloped in animals given untreated virus but the protection against 
intranasal  and  subcutaneous test  inoculation is  still  apparently  as 
staunch in the first group as in the second.  It should be noted, how- 
ever, that the resistance conferred by active virus is not in itself abso- 
lutely solid (see  Table IV, for example, which reveals that three of 
sixteen animals succumbed to an intracerebral, and one of four to an 
intranasal test, 185 to 240 days after vaccination). 
Finally, small amounts of virus are not activated by large amounts 
of inactive, formolized tissue.  This factor, taken together with other 
experimental findings, points to the fact that the immunity produced 
by the inactivated vaccines is not dependent on the presence in them 
of possible residual active virus. 
DISCUSSION 
This paper concerns itself with a  study, by quantitative methods, 
of (a) the immunization of guinea pigs and mice with inactivated, for- 
molized virus of equine encephalomyelitis and  (b)  certain phases of 
the mechanism underlying the development of this induced resistance. 
The materials of the immunizing preparation are mouse or guinea 
pig passage virus treated with formalin and by rigorous tests, made 
as  complete as  is  possible, found to  be  free from active virus.  If 
minute amounts of active virus may have been missed by means of the 
methods employed for its detection, such quantities by themselves, or 
deliberately added to ineffective formolized tissue, fail to give rise to 
protection.  In other words, the protection is produced by some other 
means than minute amounts of virus possibly residual in the vaccines. 
Why such formolized preparations should be effective for immuniza- 
tion is not definitely known.  Yet light may be thrown on the problem 
by reference to experiments here described and to the recorded findings 
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In a  test already mentioned, part of some fresh, infected brain was 
immersed  in  glycerol  and  part  in  formalin.  The  formotized fresh 
material  proved  antigenic;  the  formolized  glycerolated  substance, 
non-immunizing.  If the assumption is made that the virus content of 
both portions of the brain was equal before chemical treatment, it fol- 
lows that formalin itself has the particular property of preserving the 
antigenic complex, while glycerol has not. 
Again, evidence is at hand which indicates that the power of inac- 
tivated, formolized virus to immunize depends on the high virus con- 
tent  of  the  tissues with  which  the  vaccines  are  made.  While  this 
factor is also noted in canine distemper (11) and Rift Valley fever (12) 
viruses, it is not generally applicable,  since negative or inconclusive 
results  have  been  reported  for  the  antigenicity  of  formolized  vac- 
cinia (13) and yellow fever (14) viruses.  Yet the latter two agents can 
be diluted as high as 10  -7 and 10  -~ and still be infective in susceptible 
animals.  On the other hand, Bedson (15) protected guinea pigs with 
inactivated, formolized herpes virus vaccines made from tissues infec- 
tive, before formolization, in limiting dilutions as low as 10  -3 or  10  -4. 
Bedson also found that while inactivated material induced immunity, 
10 M.I.D. of active herpes virus were ineffective. 
It  is of  interest,  furthermore,  that  when  formolized  vaccines are 
neutralized  with  ammonium  hydroxide  before  storage,  their  anti- 
genicity is rapidly lost.  However this may be, vaccines kept in con- 
tact with formalin over long periods of time retain  their immunizing 
capacity.  Our results confirm the findings of Shahan and Giltner (16) 
on this point:  Unneutralized vaccines were still effective after storage 
in the cold for at least 65 days.  A similar stability has been noted with 
formoUzed Rift Valley fever (12) and dog distemper (11) viruses.  6 
Bedson observed (15) that formolized herpes material  is more resistant  to 
steaming than  active virus.  The  encephalomyelitis virus apparently  differs in 
this respect.  Forty mice in five groups of eight each were treated  as follows: 
Mice of group I received formolized vaccine; those of group II, the same, steamed 
30 minutes; group III, the same steamed 60 minutes.  Mice of group IV received 
active  virus  steamed  30 minutes  and  group V the same steamed  60 minutes. 
The same virus sample entered into the preparation of both materials employed 
in the five groups.  10 days later, all animals were given an intracerebral test with 
> 10 < 50 ~.L.9. and only the mice of group I  (formolized vaccine, not steamed) 
resisted the test; all mice of the other groups succumbed to fatal encephalitis. 764  IMMUNIZATION  WITH  ENCEPHALOMYELITIS  VIRUS.  II 
On another point of comparison with  other viruses: Laidlaw and 
Dunkin (11) record that vaccines prepared from distemper tissues of 
dogs are of little value for immunizing ferrets and similarly for ferret 
tissue in dogs.  They believe that the lessened response to heterologous 
vaccines may be due to the clogging of the antibody mechanism of the 
recipients with multiple antigens.  Shahan and Giltner (16) state that 
guinea pigs are usually more solidly protected against an intracerebral 
test by means of homologous encephalomyelitis tissue than with horse 
material.  In our hands, both fresh mouse and guinea pig brain after 
formolization proved equally effective as antigens. 
Since now and again one or another point is found which coincides 
with that existing in other formolized viruses used in preventive inocu- 
lations, and since others are widely separated, it is necessary to empha- 
size that the findings here reported on the encephalomyelitis virus do 
not necessarily apply to other viruses. 
We leave now the discussion of the theoretical aspects of the prob- 
lem to consider certain practical bases on which the formolized vaccine 
might be used in actual field immunization, especially in places where 
the disease is enzootic. 
It has been shown that the degree of induced resistance is in propor- 
tion to the quantity of vaccine given.  Yet, no experimental evidence 
can be  adduced from the total amounts of material inoculated--in 
mice 0.5 to 1.0 cc., in guinea pigs, 2 cc., and in horses (16), 50 cc.--that 
there is a  body weight/quantity of inoculum ratio required for suc- 
cessful immunization. 
Again,  experimental  and  epidemiological findings  indicate  that 
equine encephalomyelitis is a blood-borne infection that is transmitted 
by insect vectors.  It is plain that a method of immunization by means 
of active virus is not without danger of setting up loci of infection and 
spread of the disease.  From the work of Shahan and Giltner (7,  16) 
and our own, we believe that by the use of inactivated, formolized 
vaccines, the danger  of circulation  of virus or of infection during immun- 
ization  is  removed  and  that  such  material  might  render  horses 
resistant to the natural disease for a period of time sufficiently long 
to be of practical value.  6 HERALD  R.  COX  AND  PETER  K.  OLITSKY  765 
CONCLUSION 
From a  study by quantitative  methods,  the conclusion is reached 
that a resistance of high degree may be induced in guinea pigs and mice 
against experimental equine encephalomyelitis by means of formolized 
vaccines in which no active virus can be demonstrated.  The induced 
resistance  is not due  to residual  traces of active virus which  might 
possibly have escaped detection in the formolized tissue preparations. 
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